[A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE